Open
Cancerfree Biotech致力於通過液體活檢分析循環中的腫瘤細胞。他們獲得專利的仿生類器官培養系統目前可以在42種不同類型的實體瘤中生長罕見的CTC (circulating tumor cell)。在為患者選擇治療方法之前，醫生可以參考從患者體內分離出的癌細胞並進行定制的藥物敏感性測試。
Cancerfree Biotech Ltd. is based on innovative precision medicine and focuses on in vitro amplification of Circulating tumor cells Derived Organoid (CDO) and the related analysis. The proprietary platform E.V.A. (Ex Vivo Avatar) can fast expand patient-derived cancer cells from blood and provide patients a precision drug screening report for developing strategies against cancers at all stages. Furthermore, this technology can be a critical component for other cancer industry, such as cell therapy and new drug development. Cancerfree Biotech Ltd. tries to bring the achievement of the laboratory’s research to society in order to be the help of patients and physicians.
Cancerfree Biotech Ltd. is based on innovative precision medicine and focuses on in vitro amplification of Circulating tumor cells Derived Organoid (CDO) and the related analysis. The proprietary platform E.V.A. (Ex Vivo Avatar) can fast expand patient-derived cancer cells from blood and provide patients a precision drug screening report for developing strategies against cancers at all stages. Furthermore, this technology can be a critical component for other cancer industry, such as cell therapy and new drug development. Cancerfree Biotech Ltd. tries to bring the achievement of the laboratory’s research to society in order to be the help of patients and physicians.